BIOCOMO
Biocomo, Inc. is a drug discovery venture that works on research and development of new vaccines in collaboration with Professor Tetsuya Nosaka , Infectious Disease Control Medicine and Molecular Genetics, Mie University Graduate School of Medicine.
BIOCOMO
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2008-05-30
Address:
Mie, Mie, Japan
Country:
Japan
Website Url:
http://www.biocomo.jp
Status:
Active
Contact:
059-392-7333
Email Addresses:
[email protected]
Technology used in webpage:
Nginx YouTube SAKURA Internet ASAHINET DNS Gehirn
Similar Organizations
Huvet Bio
Huvet Bio is engaged in the research and development of bio pharmaceuticals.
Sphaera Pharma
Sphaera Pharma is engaged in the discovery and development of pharmaceutical drugs.
Current Employees Featured
Founder
Official Site Inspections
http://www.biocomo.jp Semrush global rank: 5.27 M Semrush visits lastest month: 1.56 K
- Host name: www1564.sakura.ne.jp
- IP address: 219.94.163.204
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
More informations about "BioComo"
BioComo
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. 国立大学法 …See details»
BioComo - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +81 059-392-7333 Biocomo, Inc. is a drug discovery venture that works on research and development of new …See details»
代表取締役ご挨拶 – バイオコモ株式会社 - BioComo
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. 国立大学法 …See details»
BioComo - Overview, News & Similar companies | ZoomInfo.com
BioComo contact info: Phone number: +81 593927333 Website: www.biocomo.jp What does BioComo do? BioComo, a biotech company founded at Mie Prefecture Japan in May 2008, is …See details»
BioComo, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore BioComo, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 7 literature, Drug:BC-PIV SARS-CoV-2. ... biocomo.jp. Last update 01 Nov 2024. Overview. …See details»
Biocomo Inc. - Products, Competitors, Financials, Employees ...
Key Respiratory Syncytial Virus Companies: GlaxoSmithKline, MedImmune, ReViral, Pfizer, Sanofi, BioComo, IMV, Shionogi, Aridis Pharmaceuticals, ADMA Biologics, Enanta …See details»
BioComo - Golden
BioComo is a Mie, Japan-based biotech company engaged in the development of vaccines for cancer and infectious diseases. ... Contents. biocomo.jp. Is a. Company. Organization. …See details»
BioComo Company Profile - Office Locations, Competitors ... - Craft
BioComo Incorporation is a biotech company engaged in the development of biological vaccines. Its technology can be applied to the production of vaccines for the prevention of infections …See details»
Mie University and BioComo Inc. Team up to Develop Nasal Spray …
Apr 25, 2024 For more information, please visit https://www.mie-u.ac.jp Contacts: [email protected] About BioComo Inc. BioComo is a biotech company founded in May 2008, developing …See details»
会社概要 – バイオコモ株式会社 - BioComo
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. 国立大学法 …See details»
Biocomo - Company Profile - Tracxn
Nov 2, 2024 Biocomo - Manufacturer of vaccine for different viral-based infectious diseases. Biocomo has 350 competitors.See details»
プラットフォーム・技術 – バイオコモ株式会社 - BioComo
Mie University and BioComo Inc. Team up to Develop Nasal Spray Vaccine against Respiratory Syncytial Virus in Japan with the Manufacturing Contractor, TFBS Bioscience Inc. 国立大学法 …See details»
BioComo Inc. - BioCentury Company Profiles - BCIQ
BioComo Inc. - BioCentury Company Profiles for the biopharma industrySee details»
MediciNova Announces SARS-CoV-2 Vaccine Joint Development …
Jul 27, 2020 BioComo, a biotech company founded at Mie Prefecture Japan in May 2008, is developing cutting-edge technology platforms for creating the novel and predominant vaccine …See details»
GenScript and BioComo Join Forces to Accelerate Novel Intranasal …
Dec 1, 2021 BioComo is dedicated to inventing new vaccines for both global infection threats as well as malignant tumors. For more information visit www.biocomo.jp. ... and manufacturing …See details»
BioComo - Contacts, Employees, Board Members, Advisors & Alumni
Organization. BioComo . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. BioComo has 2 current …See details»
Masayuki Fukumura - Representative Director and Founder
Primary Organization . BioComo . ... Masayuki Fukumura is the Representative Director and Founder at BioComo. BioComo Representative Director and Founder. Recent News and …See details»
GenScript and BioComo Join Forces to Accelerate Novel Intranasal …
Dec 1, 2021 BioComo is dedicated to inventing new vaccines for both global infection threats as well as malignant tumors. For more information visit www.biocomo.jp. About GenScript …See details»
www.biocomo.com
Www.biocomo.comSee details»